<DOC>
	<DOC>NCT00966316</DOC>
	<brief_summary>The purpose of this study is to determine whether the clinical pathway for acute ischemic stroke(with combination of traditional Chinese medicine and western medicine) is able to improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of Clinical Pathway</brief_summary>
	<brief_title>Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke</brief_title>
	<detailed_description>Eligibility Ages Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Those clinically diagnosed with acute ischemic stroke ； 18-85 years old； Over 6 hours and within 14 days from onset 4&lt;=NIHSS &lt;=22; Informed consent signed by patient or his/her family ； Exclusion Criteria: Hemorrhagic stroke; Cerebral hernia; Serious heart, liver, lung, kidney functional failure，malignancy; Not cooperative with physician; Psychological disorder; Already taken part in other clinical drug trial within the past 3 months</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Ischemic stroke diagnosed with both criteria of traditional Chinese medicine and western medicine； 1885 years old； Over 6 hours and within 14 days from onset 4&lt;=NIHSS &lt;=22; Informed consent signed by patient or his/her family ； Hemorrhagic stroke; Cerebral hernia; Serious heart, liver, lung, kidney functional failure,malignancy; Not cooperative with physician; Psychological disorder; Already taken part in other clinical drug trial within the past 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Acute Ischemic Stroke；clinical pathway;TCM；</keyword>
</DOC>